Cite
HARVARD Citation
Yau, T. et al. (2023). Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology. 41 (9), pp. 1747-1757. [Online].